Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

被引:2170
作者
Stambolic, V
Suzuki, A
de la Pompa, JL
Brothers, GM
Mirtsos, C
Sasaki, T
Ruland, J
Penninger, JM
Siderovski, DP
Mak, TW
机构
[1] Amgen Inst, Toronto, ON, Canada
[2] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada
[3] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada
[4] Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada
关键词
D O I
10.1016/S0092-8674(00)81780-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PTEN is a tumor suppressor with sequence homology to protein tyrosine phosphatases and the cytoskeletal protein tensin. mPTEN-mutant mouse embryos display regions of increased proliferation. In contrast, mPTEN-deficient immortalized mouse embryonic fibroblasts exhibit decreased sensitivity to cell death in response to a number of apoptotic stimuli, accompanied by constitutively elevated activity and phosphorylation of protein kinase B/Akt, a crucial regulator of cell survival. Expression of exogenous PTEN in mutant cells restores both their sensitivity to agonist-induced apoptosis and normal pattern of PKB/Akt phosphorylation. Furthermore, PTEN negatively regulates intracellular levels of phosphatidylinositol (3,4,5) trisphosphate in cells and dephosphorylates it in vitro. Our results show that PTEN may exert its role as a tumor suppressor by negatively regulating the PI3'K/PKB/Akt signaling pathway.
引用
收藏
页码:29 / 39
页数:11
相关论文
共 59 条
[1]   Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase [J].
Ahmed, NN ;
Grimes, HL ;
Bellacosa, A ;
Chan, TO ;
Tsichlis, PN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3627-3632
[2]  
AHMED NN, 1993, ONCOGENE, V8, P1957
[3]   Mechanism of activation and function of protein kinase B [J].
Alessi, DR ;
Cohen, P .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1998, 8 (01) :55-62
[4]   3-phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase [J].
Alessi, DR ;
Deak, M ;
Casamayor, A ;
Caudwell, FB ;
Morrice, N ;
Norman, DG ;
Gaffney, P ;
Reese, CB ;
MacDougall, CN ;
Harbison, D ;
Ashworth, A ;
Bownes, M .
CURRENT BIOLOGY, 1997, 7 (10) :776-789
[5]   Mechanism of activation of protein kinase B by insulin and IGF-1 [J].
Alessi, DR ;
Andjelkovic, M ;
Caudwell, B ;
Cron, P ;
Morrice, N ;
Cohen, P ;
Hemmings, BA .
EMBO JOURNAL, 1996, 15 (23) :6541-6551
[6]   MOLECULAR ALTERATIONS OF THE AKT2 ONCOGENE IN OVARIAN AND BREAST CARCINOMAS [J].
BELLACOSA, A ;
DEFEO, D ;
GODWIN, AK ;
BELL, DW ;
CHENG, JQ ;
ALTOMARE, DA ;
WAN, MH ;
DUBEAU, L ;
SCAMBIA, G ;
MASCIULLO, V ;
FERRANDINA, G ;
PANICI, PB ;
MANCUSO, S ;
NERI, G ;
TESTA, JR .
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (04) :280-285
[7]   A RETROVIRAL ONCOGENE, AKT, ENCODING A SERINE-THREONINE KINASE CONTAINING AN SH2-LIKE REGION [J].
BELLACOSA, A ;
TESTA, JR ;
STAAL, SP ;
TSICHLIS, PN .
SCIENCE, 1991, 254 (5029) :274-277
[8]  
BIGNER SH, 1988, CANCER RES, V48, P405
[9]  
Cairns P, 1997, CANCER RES, V57, P4997
[10]   EGF RECEPTOR AMPLIFICATION AND EXPRESSION IN HUMAN BRAIN-TUMORS [J].
CHAFFANET, M ;
CHAUVIN, C ;
LAINE, M ;
BERGER, F ;
CHEDIN, M ;
ROST, N ;
NISSOU, MF ;
BENABID, AL .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (01) :11-17